Interleukin Genetics Inc Sample Contracts

AutoNDA by SimpleDocs
OF DIGISPHERE, LLC
Operating Agreement • October 29th, 1997 • Medical Science Systems Inc • Services-medical laboratories • Delaware
RECITALS
Purchase Agreement • March 7th, 2001 • Interleukin Genetics Inc • Services-medical laboratories • New York
EXHIBIT 10.1 STOCK PURCHASE AGREEMENT
Stock Purchase Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
OFFICE LEASE ONE INTERNATIONAL CENTRE
Office Lease • October 8th, 1997 • Medical Science Systems Inc • Texas
RECITALS --------
Warrant Agreement • October 8th, 1997 • Medical Science Systems Inc • California
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 5th, 2010 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March 5, 2010, between Interleukin Genetics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

AutoNDA by SimpleDocs
CONFIDENTIAL
Placement Agent Agreement • March 5th, 2010 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • New York
COMMON STOCK PURCHASE WARRANT
Common Stock Purchase Warrant • March 5th, 2010 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the 5 year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Interleukin Genetics, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • August 1st, 2016 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances

This Registration Rights Agreement (this “Agreement”) is made and entered into as of July 29, 2016, between Interleukin Genetics, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

GUARANTY
Guaranty • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Michigan

Pyxis Innovations Inc., a Delaware corporation, is a wholly owned subsidiary of Alticor Inc., a Michigan corporation ("Alticor").

Contract
Warrant Agreement • April 17th, 2017 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware

THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THIS WARRANT.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!